4//SEC Filing
Johnson John Paul 4
Accession 0001628908-23-000039
CIK 0001628908other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:37 PM ET
Size
8.2 KB
Accession
0001628908-23-000039
Insider Transaction Report
Form 4
Johnson John Paul
Chief Financial Officer
Transactions
- Award
Class A Common Stock
2023-03-01+20,413→ 212,717 total - Tax Payment
Class A Common Stock
2023-03-01$35.26/sh−3,681$129,792→ 209,036 total - Tax Payment
Class A Common Stock
2023-03-02$35.15/sh−9,020$317,053→ 200,016 total
Footnotes (4)
- [F1]Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. Omnibus Incentive Compensation Plan.
- [F2]Securities vest at a rate of 34% on March 1, 2024, and 33% on March 1, 2025, and March 1, 2026.
- [F3]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F4]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001782040
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:37 PM ET
- Size
- 8.2 KB